Anti‐VEGF‐A therapy has not been licensed for psoriasis, but there are seven case reports of patients who have experienced psoriasis improvement while receiving anti‐VEGF‐A therapy for the treatment of cancer.106, 107, 108, 109, 110, 111, 112, 113. This evidence concerns the gene VEGFA and psoriasis.